Finally, stimulation of full-length ErbB2 receptors in SKBr3 breast cancer cells increased both SLC4A7 expression and HCO−3-dependent pHi recovery (Gorbatenko et al., 2014). Here, SLC4A7 is linked to breast carcinoma.